Viewing Study NCT01482104


Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2025-12-31 @ 9:14 PM
Study NCT ID: NCT01482104
Status: COMPLETED
Last Update Posted: 2017-10-27
First Post: 2011-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
Sponsor: Norwegian University of Science and Technology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module